Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
FLEX LNG
FLNG
$1.66B
| $603K | ﹤0.01% |
22,317
-20,641
| -48% | -$560K |
|
2827
Donegal Group Class A
DGICA
$719M
| $603K | ﹤0.01% |
46,820
-2,706
| -5% | -$35.9K |
|
|
ARR
2828
Armour Residential REIT
ARR
$2.38B
| $602K | ﹤0.01% |
31,073
-13,182
| -30% | -$251K |
|
2829
Andersons Inc
ANDE
$2.28B
| $602K | ﹤0.01% |
12,141
-16,894
| -58% | -$903K |
|
2830
Tarsus Pharmaceuticals
TARS
$2.85B
| $601K | ﹤0.01% |
22,125
-8,183
| -27% | -$275K |
|
2831
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.4B
| $601K | ﹤0.01% |
29,860
+29,800
| +49,667% | +$640K |
|
2832
NETGEAR
NTGR
$626M
| $601K | ﹤0.01% |
39,260
-21,338
| -35% | -$298K |
|
2833
SandRidge Energy
SD
$503M
| $599K | ﹤0.01% |
46,325
+4,242
| +10% | +$58.7K |
|
2834
Methanex
MEOH
$4.14B
| $598K | ﹤0.01% |
12,400
-11,588
| -48% | -$577K |
|
2835
Southern Missouri Bancorp
SMBC
$849M
| $598K | ﹤0.01% |
13,277
-4,134
| -24% | -$172K |
|
2836
Cohu
COHU
$2.51B
| $595K | ﹤0.01% |
17,978
-24,263
| -57% | -$753K |
|
2837
SIGA Technologies
SIGA
$224M
| $593K | ﹤0.01% |
78,193
+14,885
| +24% | +$121K |
|
2838
Zumiez
ZUMZ
$333M
| $593K | ﹤0.01% |
30,453
-13,283
| -30% | -$230K |
|
2839
CALL
AMC Entertainment Holdings
AMC
$2.25B
| $593K | ﹤0.01% |
+119,100
| New | +$478K |
|
2840
Usana Health Sciences
USNA
$276M
| $592K | ﹤0.01% |
13,090
-5,950
| -31% | -$274K |
|
|
MRX
2841
Marex Group Limited Ordinary Shares
MRX
$4.51B
| $592K | ﹤0.01% |
+29,594
| New | +$582K |
|
2842
Heron Therapeutics
HRTX
$93.6M
| $589K | ﹤0.01% |
168,346
+31,887
| +23% | +$98K |
|
2843
Mercury Insurance
MCY
$5.94B
| $589K | ﹤0.01% |
11,087
-13,192
| -54% | -$715K |
|
2844
BlackRock Flexible Income ETF
BINC
$16.1B
| $587K | ﹤0.01% |
11,253
| – | – |
|
2845
Tompkins Financial
TMP
$1.41B
| $587K | ﹤0.01% |
12,000
-10,318
| -46% | -$475K |
|
2846
Global E Online
GLBE
$7.06B
| $587K | ﹤0.01% |
16,173
-49,455
| -75% | -$1.6M |
|
2847
Pulmonx
LUNG
$88.5M
| $586K | ﹤0.01% |
92,430
-20,378
| -18% | -$157K |
|
2848
Compass Diversified
CODI
$835M
| $584K | ﹤0.01% |
26,688
-32,525
| -55% | -$732K |
|
|
CIM
2849
Chimera Investment
CIM
$1.01B
| $584K | ﹤0.01% |
45,640
-22,978
| -33% | -$291K |
|
2850
Financial Institutions
FISI
$822M
| $583K | ﹤0.01% |
30,192
-5,348
| -15% | -$94.8K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.